Abbott Laboratories– tag –
-
New Technology
FDA Approves Finger-Prick Free Dexcom Stelo and Abbott Libre CGMs, Revolutionizing Metabolic Management for Non-Insulin Users
Mattioli 1885 / GoodRx USA Overview The FDA has approved continuous glucose monitoring (CGM) systems like Dexcom Stelo and Abbott's Lingo (and FreeStyle Libre series), eliminating the need for traditional finger-prick tests and marking a... -
Biosensors & POCT
Abbott Secures CE Mark for World’s First Dual Glucose-Ketone Sensor, Revolutionizing DKA Management
MedTech Dive USA Overview Abbott has received European CE Mark approval for its Libre Duo and Libre Duo 10 Day systems, the world's first dual-analyte sensors capable of continuously measuring both glucose and ketones. This technology ai...